Hypocitraturic calcium oxalate nephrolithiasis

DBCOND0023599Signs, Symptoms, and General PathologiesUrogenital Diseases

Hypocitraturic calcium oxalate nephrolithiasis is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Oxalate crystalluria · Kidney Stones, Urolithiasis, Hypocitraturia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000751499ICD-10R82.998SNOMED CT207328004MedDRA10011509UMLSC0151579

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Hypocitraturic calcium oxalate nephrolithiasis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In